Robbins & Myers 8-K Robbins & Myers Reports Strong Finish to Record Year

Exhibit 99.1

Investor Relations
+1 (937) 458-6600

ROBBINS & MYERS REPORTS STRONG FINISH TO RECORD YEAR

Record Fourth Quarter Performance;
Continued Growth Expected in Fiscal 2009

DAYTON, OHIO, October 9, 2008...Robbins & Myers, Inc. (NYSE: RBN)today reported diluted net earnings per share (DEPS) of $0.88 for its fiscal fourth quarter ended August 31, 2008, including $0.12 from the release of tax valuation allowances for existing net operating losses (NOL) and a $0.02 gain from the fourth quarter sale of an unused property. In the prior year fourth quarter, the Company reported $0.55 of DEPS, which included a $0.03 gain from the sale of an unused property.

Robbins & Myers earned $2.52 per diluted common share for the full year ended August 31, 2008, as compared with $1.48 in the prior year, an increase of 70%. Fiscal 2008 results included $0.17 of NOL benefits and $0.18 from three asset sale gains reported throughout the year, and prior year results included $0.06 of benefit from asset sales, net of restructuring costs. Excluding these items, DEPS increased from $1.42 in fiscal 2007 to $2.17 in fiscal 2008, primarily as a result of higher sales, an improved cost structure and a lower normalized effective tax rate.

Fiscal fourth quarter 2008 sales increased 10% over the prior year fourth quarter to $228 million, and orders increased 5% to $198 million. Excluding the impact from acquired and disposed product lines and currency translation, organic sales increased 3%, with increases noted in all three business platforms, and organic orders increased 4%, led by strength in energy markets. For the full fiscal 2008 year, sales increased 13% over the prior year to $787 million, and orders increased 13% to $813 million. On an organic basis, full year sales and orders grew 6% and 7%, respectively.

“I am pleased to report a strong finish to fiscal 2008,” said Peter C. Wallace, President and Chief Executive Officer of Robbins & Myers, Inc. “We again achieved year-over-year sales and order growth, reflecting market strength and our successful customer and market-based initiatives. With our improved cost structure, we leveraged our sales growth into even higher earnings growth. Our focus on cash flow enabled us to generate nearly $90 million of cash from operations during the year, 38% higher than last year. I thank our worldwide associates for their contributions towards our record performance.”

The Company reported fourth quarter 2008 earnings before interest, taxes and minority interest (EBIT) of $41 million. Excluding the gains from property sales in the fourth quarters of fiscal 2007 and 2008, fourth quarter 2008 adjusted EBIT increased 15% over prior year fourth quarter results. The adjusted EBIT margin of 17.7% for fiscal Q4 2008 is 80 basis points higher than the comparable prior year period. Robbins & Myers also reported $44 million of adjusted EBITDA in the fourth quarter of 2008 and $137 million for the full year.

Mr. Wallace commented, “Our backlog and recent order activity give us a good start to the new fiscal year. We continue to make progress in our continuous improvement

initiatives, providing another avenue of long-term earnings growth. We are actively pursuing acquisition opportunities that could expand our product offering and geographic reach. The Company begins fiscal 2009 in a secure financial position with $123 million of cash and an undrawn senior credit facility provided by six banks. We are well-positioned as we start fiscal 2009 but also recognize the economic environment has become more challenging.”

Robbins & Myers announced its expectations for fiscal 2009 DEPS of $2.40-$2.55, which represents an 11-18% increase over fiscal 2008 adjusted DEPS of $2.17 (excluding NOL benefits and asset sale gains). The Company also expects fiscal first quarter 2009 DEPS of $0.45-$0.50, as compared with actual results of $0.40 in the first quarter of fiscal 2008.

Fourth Quarter Results by Segment

All comparisons are made against the comparable year-ago quarterly period unless otherwise stated.

TheFluid Management segment reported fourth quarter sales of $90 million, an 8% increase, and orders of $99 million, a 23% increase. Excluding currency exchange rate effects, organic sales increased 6% and organic orders improved 23% on continued strength in energy markets and new product contributions. EBIT grew 11% to $27 million, and EBIT margins expanded 100 basis points to 29.5%.

TheProcess Solutions segment reported sales of $87 million in the fourth quarter, a 9% increase, and orders of $69 million, a 4% decrease. Excluding the effects of currency exchange rates and an acquisition, organic sales increased 1% and organic orders decreased 4%. The segment noted strong order activity in September and expects year-over-year order growth in the first quarter of fiscal 2009. The segment earned $12 million of EBIT in the fourth quarter of 2008, including a $1 million gain on the sale of an unused property. Excluding this gain, adjusted EBIT margins in the fourth quarter were comparable to the prior year.

TheRomaco segment reported fourth quarter sales of $50 million, a 16% increase, and orders of $30 million, down 19%. Excluding the impact from currency exchange rates, organic sales increased 2% and orders declined 23%. The segment noted strong order activity in September and expects year-over-year order growth in the first quarter of fiscal 2009. Romaco achieved record EBIT of $9 million and record EBIT margins of 18.0%.

Conference Call to Be Held on October 10 at 10:00 AM (EDT)

A conference call to discuss these results has been scheduled for 10:00 AM EDT Friday, October 10, 2008, which can be accessed at www.robn.com or by dialing 800-901-5241 (US/Canada) or +1-617-786-2963, using conference ID # 16293860. Replays of the call can be accessed by dialing 888-286-8010 (U.S./Canada) or +1- 617-801-6888, both using replay ID # 85108752.

About Robbins & Myers

Robbins & Myers, Inc. is a leading supplier of engineered equipment and systems for critical applications in global energy, industrial, chemical and pharmaceutical markets.

In this release the Company refers to various non-GAAP measures, including EBIT, Adjusted EBIT, EBITDA (earnings before interest, taxes, depreciation and amortization) and Adjusted EBITDA. The Company uses these measures to evaluate its performance and believes these measures are helpful to investors in assessing its performance. Reconciliations of these measures to comparable GAAP measures are provided further below in this release.

In addition to historical information, this release contains forward-looking statements identified by use of words such as “expects,” “anticipates,” “believes,” and similar expressions. These statements reflect management’s current expectations and involve known and unknown risks, uncertainties, contingencies and other factors that could cause actual results, performance or achievements to differ materially from those stated. The most significant of these risks and uncertainties are described in ourForm 10-K andForm 10-Q reports filed with the Securities and Exchange Commission and include, but are not limited to: a significant decline in capital expenditures in the specialty chemical and pharmaceutical industries; a major decline in oil and natural gas prices; foreign exchange rate fluctuations; work stoppages related to union negotiations; customer order cancellations; business disruptions caused by the implementation of business computer systems; the possibility of product liability suits that could hurt our business; events or circumstances which result in an impairment of assets; the potential impact of U.S. and foreign legislation, government regulations, and other governmental action, including those relating to export and import of products and materials, and changes in the interpretation and application of such laws and regulations; the outcome of audit, compliance, administrative or investigatory reviews; and general economic conditions that can affect demand in the process industries. Except as otherwise required by law, we do not undertake any obligation to publicly update or revise these forward- looking statements to reflect events or circumstances after the date hereof.

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET
     (Unaudited)

(in thousands)	August 31, 2008		August 31, 2007
ASSETS
Current Assets:
Cash and cash equivalents	$	123,405	$	116,110
Accounts receivable		153,648		152,779
Inventories		109,797		99,196
Other current assets		8,017		7,410
Deferred taxes		13,476		11,178
Total Current Assets		408,343		386,673
Goodwill & Other Intangible Assets		285,759		278,422
Deferred Taxes		21,969		9,583
Other Assets		10,931		12,196
Property, Plant & Equipment		137,715		129,269
	$	864,717	$	816,143
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	86,012	$	78,890
Accrued expenses		102,876		105,394
Current portion of long-term debt		3,192		72,522
Total Current Liabilities		192,080		256,806
Long-Term Debt — Less Current Portion		30,435		30,553
Deferred Taxes		44,628		24,818
Other Long-Term Liabilities		97,557		91,448
Shareholders’ Equity		500,017		412,518
	$	864,717	$	816,143

Page 4 of 8

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENT
     (Unaudited)

	Three Months Ended						Twelve Months Ended
	August 31,			August 31,			August 31,			August 31,
(in thousands, except per share data)	2008			2007			2008			2007
Sales	$	227,754		$	207,034		$	787,168		$	695,393
Cost of sales		143,413			134,820			496,906			453,052
Gross profit		84,341			72,214			290,262			242,341
SG&A expenses		44,114			37,192			167,229			151,520
Other income		(835	)		(1,303	)		(7,631	)		(3,461	)
Income before interest and income taxes		41,062			36,325			130,664			94,282
Interest expense, net		268			893			2,031			5,243
Income before income taxes and minority interest		40,794			35,432			128,633			89,039
Income tax expense		9,812			15,963			39,099			36,866
Minority interest		350			557			2,132			1,468
Net income	$	30,632		$	18,912		$	87,402		$	50,705
Net Income Per Share:
Basic	$	0.88		$	0.55		$	2.53		$	1.49
Diluted	$	0.88		$	0.55		$	2.52		$	1.48
Weighted Average Common Shares Outstanding:
Basic		34,685			34,242			34,524			34,050
Diluted		34,836			34,384			34,718			34,212

Page 5 of 8

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED BUSINESS SEGMENT INFORMATION
     (Unaudited)

	Three Months Ended						Twelve Months Ended
	August 31,			August 31,			August 31,			August 31,
(in thousands)	2008			2007			2008			2007
Sales
Fluid Management	$	90,499		$	84,047		$	322,868		$	292,283
Process Solutions		87,021			79,579			313,604			273,890
Romaco		50,234			43,408			150,696			129,220
Total	$	227,754		$	207,034		$	787,168		$	695,393
Income Before Interest and Income Taxes (EBIT)
Fluid Management	$	26,671		$	23,963		$	91,319		$	76,973
Process Solutions		11,956			10,528			37,570			31,941
Romaco		9,046			6,721			20,603			2,612
Corporate and Eliminations		(6,611	)		(4,887	)		(18,828	)		(17,244	)
Total	$	41,062		$	36,325		$	130,664		$	94,282
Depreciation and Amortization
Fluid Management	$	1,970		$	2,260		$	6,993		$	7,376
Process Solutions		1,595			1,369			6,753			6,224
Romaco		491			583			1,869			2,090
Corporate and Eliminations		131			252			634			934
Total	$	4,187		$	4,464		$	16,249		$	16,624
Orders
Fluid Management	$	99,174		$	80,406		$	343,079		$	301,941
Process Solutions		68,872			71,402			324,542			284,371
Romaco		29,754			36,896			145,377			133,536
Total	$	197,800		$	188,704		$	812,998		$	719,848
Backlog
Fluid Management	$	63,168		$	42,956		$	63,168		$	42,956
Process Solutions		123,529			98,914			123,529			98,914
Romaco		51,283			51,951			51,283			51,951
Total	$	237,980		$	193,821		$	237,980		$	193,821

These results include income and expense relating to special items that are described in greater detail in the accompanying “Reconciliation of Net Income to the Non-GAAP Measures of EBIT, EBITDA, Adjusted EBIT and Adjusted EBITDA”.

Page 6 of 8

ROBBINS & MYERS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
     (Unaudited)

	Three Months Ended						Twelve Months Ended
	August 31,			August 31,			August 31,			August 31,
(in thousands)	2008			2007			2008			2007
Operating activities:
Net income	$	30,632		$	18,912		$	87,402		$	50,705
Depreciation and amortization		4,187			4,464			16,249			16,624
Other, net		5,985			32,790			(14,091	)		(2,216	)
Cash provided by operating activities		40,804			56,166			89,560			65,113
Investing activities:
Capital expenditures, net of nominal disposals		(9,331	)		(5,109	)		(22,114	)		(16,536	)
Proceeds from sales of product line/ facilities		1,291			2,330			8,484			13,712
Acquisition of business, net of cash acquired		0			0			(5,061	)		0
Cash used by investing activities		(8,040	)		(2,779	)		(18,691	)		(2,824	)
Financing activities:
Proceeds (Payments) of long-term debt, net		667			(585	)		(69,448	)		(2,456	)
Other, net		344			682			3,576			6,663
Cash provided (used) by financing activities		1,011			97			(65,872	)		4,207
Exchange rate impact on cash		(2,114	)		167			2,298			1,249
Increase in cash		31,661			53,651			7,295			67,745
Cash at beginning of period		91,744			62,459			116,110			48,365
Cash at end of period	$	123,405		$	116,110		$	123,405		$	116,110

Page 7 of 8

ROBBINS & MYERS, INC. AND SUBSIDIARIES
RECONCILIATION OF NET INCOME TO THE NON-GAAP MEASURES OF EBIT, EBITDA, ADJUSTED EBIT AND ADJUSTED
     EBITDA
     (Unaudited)

	Three Months Ended						Twelve Months Ended
	August 31,			August 31,			August 31,			August 31,
(dollar amounts in thousands)	2008			2007			2008			2007
Net income	$	30,632		$	18,912		$	87,402		$	50,705
Interest expense, net		268			893			2,031			5,243
Income taxes		9,812			15,963			39,099			36,866
Minority interest		350			557			2,132			1,468
EBIT		41,062			36,325			130,664			94,282
Minority interest		(350	)		(557	)		(2,132	)		(1,468	)
Depreciation & amortization		4,187			4,464			16,249			16,624
EBITDA		44,899			40,232			144,781			109,438
Special items:
(1) Process Solutions segment
Net product line/facility sale gains		(835	)		—			(835	)		(5,036	)
		(835	)		—			(835	)		(5,036	)
(2) Romaco segment
Restructuring costs		—			—			—			1,818
Net product line/facility sale gains		—			(1,303	)		(6,796	)		(243	)
		—			(1,303	)		(6,796	)		1,575
Total Special Items		(835	)		(1,303	)		(7,631	)		(3,461	)
Adjusted EBIT	$	40,227		$	35,022		$	123,033		$	90,821
Adjusted EBIT margin		17.7	%		16.9	%		15.6	%		13.1	%
Adjusted EBITDA	$	44,064		$	38,929		$	137,150		$	105,977

Note: EBIT, adjusted EBIT, adjusted EBIT margin, and adjusted EBITDA are non-GAAP measures. We use these measures to evaluate our businesses, and we allocate resources to our businesses based on EBIT. EBIT is not, however, a measure of performance calculated in accordance with accounting principles generally accepted in the United States and should not be considered as an alternative to net income as a measure of operating results. Neither EBIT nor EBITDA are measures of cash available for use by management.

Page 8 of 8